|
FAM160A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.019000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.872600E-01 |
| Normal-vs-Stage2 |
8.798000E-01 |
| Normal-vs-Stage3 |
6.726000E-01 |
| Normal-vs-Stage4 |
1.384010E-04 |
| Stage1-vs-Stage2 |
6.517400E-01 |
| Stage1-vs-Stage3 |
9.712600E-01 |
| Stage1-vs-Stage4 |
2.049800E-04 |
| Stage2-vs-Stage3 |
6.799000E-01 |
| Stage2-vs-Stage4 |
1.229710E-02 |
| Stage3-vs-Stage4 |
1.640600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.962000E-01 |
| Normal-vs-AfricanAmerican |
8.566000E-01 |
| Normal-vs-Asian |
5.605200E-01 |
| Caucasian-vs-AfricanAmerican |
6.561800E-01 |
| Caucasian-vs-Asian |
4.814400E-01 |
| AfricanAmerican-vs-Asian |
4.544200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.328800E-01 |
| Normal-vs-Female |
5.623400E-01 |
| Male-vs-Female |
2.363400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.589600E-01 |
| Normal-vs-Extreme_Weight |
4.347600E-01 |
| Normal-vs-Obese |
6.328200E-01 |
| Normal-vs-Extreme_Obese |
7.470800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.232400E-01 |
| Normal_Weight-vs-Obese |
1.759550E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.632200E-01 |
| Extreme_Weight-vs-Obese |
2.455400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.680200E-01 |
| Obese-vs-Extreme_Obese |
6.161600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.616200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.507000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.545800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.693500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.521570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.821600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.417200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.363400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.361700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.514600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.901440E-01 |
| Normal-VS-Type2 PRCC |
3.196300E-03 |
| Normal-VS-KIRP CIMP |
4.118200E-01 |
| Normal-VS-Unclassified PRCC |
9.965000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.73029999994689E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.488800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.486200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.126400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.201000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.615200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.682600E-01 |
| Normal-vs-N1 |
3.020000E-01 |
| Normal-vs-N2 |
4.662100E-02 |
| N0-vs-N1 |
9.593800E-01 |
| N0-vs-N2 |
3.369600E-01 |
| N1-vs-N2 |
3.087000E-01 |
|
|
